Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diwakar R Pattabiraman

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|July 2, 2014
Tackling the cancer stem cells - what challenges do they pose?Diwakar R Pattabiraman, Robert A Weinberg
Cold Spring Harbor Symposia on Quantitative Biology|January 7, 2017
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based TherapyDiwakar R Pattabiraman, Robert A Weinberg
Cell|February 11, 2017
Emerging Biological Principles of MetastasisArthur W Lambert, Diwakar R Pattabiraman, Robert A Weinberg
Cancers|March 10, 2022
Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to BedsideMeredith S Brown, Kristen E Muller, Diwakar R Pattabiraman
Methods in Cell Biology|August 11, 2022
Quantifying epithelial-mesenchymal heterogeneity and EMT scoring in tumor samples via tyramide signal amplification (TSA)Meredith S Brown, Behnaz Abdollahi, Saeed Hassanpour, et al.
Molecular Cancer Research : MCR|September 10, 2009
Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming abilityDiwakar R Pattabiraman, Jane Sun, Dennis H Dowhan, et al.
Epigenomics|April 6, 2022
Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitionsMin Kyung Lee, Meredith S Brown, Owen M Wilkins, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Epigenomics|February 15, 2024
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast CancerHanxu Lu, Meisam Bagheri, Fred W Kolling, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|July 2, 2014
Tackling the cancer stem cells - what challenges do they pose?Diwakar R Pattabiraman, Robert A Weinberg
Cold Spring Harbor Symposia on Quantitative Biology|January 7, 2017
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based TherapyDiwakar R Pattabiraman, Robert A Weinberg
Cell|February 11, 2017
Emerging Biological Principles of MetastasisArthur W Lambert, Diwakar R Pattabiraman, Robert A Weinberg
Cancers|March 10, 2022
Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to BedsideMeredith S Brown, Kristen E Muller, Diwakar R Pattabiraman
Methods in Cell Biology|August 11, 2022
Quantifying epithelial-mesenchymal heterogeneity and EMT scoring in tumor samples via tyramide signal amplification (TSA)Meredith S Brown, Behnaz Abdollahi, Saeed Hassanpour, et al.
Molecular Cancer Research : MCR|September 10, 2009
Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming abilityDiwakar R Pattabiraman, Jane Sun, Dennis H Dowhan, et al.
Epigenomics|April 6, 2022
Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitionsMin Kyung Lee, Meredith S Brown, Owen M Wilkins, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Epigenomics|February 15, 2024
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast CancerHanxu Lu, Meisam Bagheri, Fred W Kolling, et al.
Pageof 3